Rate Control: Clinical Trials

3 trials for Rate Control, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 recruiting. 2 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable2Completed 1, Recruiting 1

Follow Rate Control: new trials by email Literature Review of Rate Control trials Research Report on Rate Control

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Treating Atrial Fibrillation in Heart Failure With Preserved Ejection Fraction: Ablation or Medication
Catheter Ablation for Atrial Fibrillation, Rate Control Medications (beta-blockers, calcium channel blockers, digoxin) - Atrial Fibrillation (AF), Heart Failure With Mildly Reduced Ejection Fraction
Not applicableRecruitingNova Scotia Health Authority842026-01-012026-10-20
Rate Control in Patients With Atrial Fibrillation
Atenolol, Bisoprolol, Metoprolol, Nebivolol, Propranolol, Diltiazem, Verapamil, digoxin - Atrial Fibrillation, Rate Control
Not applicableCompletedNational Taiwan University Hospital132020-10-212026-01-16
Catheter Ablation and Rate Control of Atrial Fibrillation in Patients With Heart Failure
Catheter Ablation, Rate Control
CompletedNanjing Medical University3942016-08-012023-07-13

Narrower conditions

Atrial Fibrillation (3)  ·  Heart Failure (1)

Broader conditions

Arrhythmias, Cardiac (3)  ·  Cardiovascular Diseases (3)  ·  Heart Diseases (3)  ·  Pathologic Processes (3)  ·  Pathological Conditions, Signs and Symptoms (3)

Interventions

Digoxin (2)  ·  Adrenergic beta-Antagonists (1)  ·  Atenolol (1)  ·  Bisoprolol (1)  ·  Calcium Channel Blockers (1)  ·  Catheter Ablation (1)  ·  Diltiazem (1)  ·  Metoprolol (1)  ·  Nebivolol (1)  ·  Propranolol (1)  ·  Verapamil (1)

Sponsors

Nanjing Medical University (1)  ·  National Taiwan University Hospital (1)  ·  Nova Scotia Health Authority (1)

Countries

Canada (1)  ·  China (1)  ·  Taiwan (1)

Top investigators

Bingjian Wang, MD (1)  ·  Chih-Chieh Yu, MD.PhD (1)  ·  Jin Geng, MD (1)